期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 45, 期 2, 页码 525-530出版社
WILEY
DOI: 10.1002/eji.201444748
关键词
innate immunity; interleukin-1 (IL-1); neuroinflammation; neutrophil
类别
资金
- British Heart Foundation
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- BBSRC [BBS/E/D/20251969] Funding Source: UKRI
- MRC [MR/K001744/1, MR/L003384/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish
- British Heart Foundation [PG/13/8/29989, FS/10/73/28464] Funding Source: researchfish
- Medical Research Council [MR/K001744/1, MR/L003384/1] Funding Source: researchfish
The immune system is implicated in a wide range of disorders affecting the brain and is, therefore, an attractive target for therapy. Interleukin-1 (IL-1) is a potent regulator of the innate immune system important for host defense but is also associated with injury and disease in the brain. Here, we show that IL-1 is a key mediator driving an innate immune response to inflammatory challenge in the mouse brain but is dispensable in extracerebral tissues including the lung and peritoneum. We also demonstrate that IL-1 alpha is an important ligand contributing to the CNS dependence on IL-1 and that IL-1 derived from the CNS compartment (most likely microglia) is the major source driving this effect. These data reveal previously unknown tissue-specific requirements for IL-1 in driving innate immunity and suggest that IL-1-mediated inflammation in the brain could be selectively targeted without compromising systemic innate immune responses that are important for resistance to infection. This property could be exploited to mitigate injury- and disease-associated inflammation in the brain without increasing susceptibility to systemic infection, an important complication in several neurological disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据